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Background: Decreased ability of muscles to respond to anabolic stimuli is part of the underlying mechanism for
muscle loss with aging. Previous studies suggest that substantial amounts of essential amino acids (EAA), whey
protein and leucine are beneficial for stimulation of acute muscle protein synthesis in older adults. However, these
studies supplied only proteins, and no bolus studies have been done with dairy products or supplements that
contained also fat and carbohydrates besides proteins. The aim of this study was to evaluate whether a specifically
designed nutritional supplement in older adults stimulates muscle protein synthesis acutely to a greater extent than
a conventional dairy product. Moreover, the combined effect with resistance exercise was studied by using a
unilateral resistance exercise protocol.
Methods: Utilizing a randomized, controlled, double blind study design, healthy older adults received a single
bolus of a high whey protein, leucine-enriched supplement (EXP: 20g whey protein, 3g total leucine, 150kcal; n = 9)
or an iso-caloric milk protein control (Control: 6g milk protein; n = 10), immediately after unilateral resistance
exercise. Postprandial mixed muscle protein fractional synthesis rate (FSR) was measured over 4h using a tracer
infusion protocol with L-[ring-13C6]-phenylalanine and regular blood and muscle sampling.
Results: FSR was significantly higher overall after EXP (0.0780 ± 0.0070%/h) vs Control (0.0574 ± 0.0066%/h (EMM± SE))
(p = 0.049). No interaction between treatment and exercise was observed (p = 0.519). Higher postprandial concentrations
of EAA and leucine are possible mediating factors for the FSR response, while plasma insulin increase did not dictate the
FSR response. Moreover, when the protein intake from the supplements was expressed per kg leg lean mass (LLM), a
significant correlation was observed with resting postprandial FSR (r = 0.48, P = 0.038).
Conclusions: Ingestion of a high whey protein, leucine-enriched supplement resulted in a larger overall postprandial
muscle protein synthesis rate in healthy older subjects compared with a conventional dairy product. This acute effect is
promising for long-term effects on parameters of muscle mass, strength and function in sarcopenic older people, which
requires further study.
Trial registration: This trial is registered in the Dutch Trial Register under number NTR1823.
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Muscle mass, strength and function decreases with
aging, and can evolve into sarcopenia, i.e. low muscle
mass and function, if the loss is sufficient [1]. It has been
hypothesized that a decreased ability of the muscle to re-
spond to anabolic stimuli, such as essential amino acids
(EAA) and leucine in a meal [2-4] or exercise [5,6], is
part of the underlying mechanism explaining the muscle
decrements in older adults.
Stable isotope studies have demonstrated that inges-
tion of amino acids can stimulate muscle protein synthe-
sis in older adults [7-9]. EAA in particular are able to
stimulate muscle protein synthesis, whereas non-EAA
(NEAA) are of less relevance for muscle anabolism
[9,10]. However, older adults required a higher dose of
EAA to stimulate muscle anabolism than younger indi-
viduals [7,11]. This suggests that the anabolic response
to amino acids at low doses is blunted in older people
[3,12]. In addition to increasing the total dose of amino
acids, diminished anabolic responsiveness with aging
could also be overcome by increasing the proportion of
leucine [12], especially at low protein intake [13]. More-
over, a protein source such as whey, that is digested rap-
idly and absorbed with a rapid elevation of plasma
leucine, could stimulate muscle protein synthesis rate to
a higher level than casein or casein hydrolysate [14,15].
Therefore, dietary strategies with a mixture of whey pro-
tein and additional leucine that significantly increase
plasma EAA and leucine are hypothesized to be benefi-
cial for a greater acute muscle anabolic response in older
adults than other proteins alone and in an amount that
is present in a conventional dairy product.
Resistance exercise is another stimulus for muscle protein
synthesis. However, since exercise also activates muscle
protein breakdown, net muscle protein balance remains
negative, i.e. with net protein breakdown, in the absence of
nutrient intake [16]. The combination of exercise prior to
amino acid supply enhanced muscle protein synthesis fur-
ther than exercise alone and resulted in net muscle protein
synthesis [17,18]. The interactive effect of amino acids and
exercise was likely due in part to exercise-stimulated blood
flow and increased amino acid delivery to the muscle [18].
It is also possible that activation of the mTOR (mammalian
target of rapamycin) pathway by exercise primed the
muscle to respond more prominently than when amino
acids were ingested alone [19]. On the other hand, older
adults apparently have impaired contraction-induced acti-
vation of mTOR signaling and muscle protein synthesis
[5,6]. Nonetheless, protein or amino acids in combination
with exercise has additive effects on muscle protein synthe-
sis in older adults although the response may be somewhat
delayed with aging [20].
The primary objective of our study was to evaluate
muscle protein synthesis in healthy older adults afterintake of a specifically designed high whey protein,
leucine-enriched nutritional supplement, compared with a
control product containing milk protein in an amount
that is typical for a single serving of a conventional dairy
product, e.g., a glass of milk. Both products contained be-
sides protein also carbohydrates and fat and thus are more
representative of conventional products or a ‘mixed meal’,
in contrast to previous studies in which only intact protein
or free amino acids were supplied. To account for a poten-
tial impact of energy density, both products were isocalo-
ric. Secondly, the combined effect on muscle protein
synthesis of nutritional supplementation with resistance
exercise was compared to nutritional supplementation
without exercise, by using an unilateral resistance exercise
protocol. We hypothesized that the nutritional supple-
ment high in whey protein and enriched in leucine would
be more effective than a typical dairy product to stimulate
muscle protein synthesis in healthy older adults. More-
over, we hypothesized that exercise would further enhance
postprandial muscle protein synthesis. These objectives
are relevant for the ultimate use of nutritional supplemen-
tation and exercise intervention in the management and
prevention of sarcopenia.
Methods
Subjects
Twenty-three healthy older adults were screened and a
total of 20 healthy older adults were enrolled in the study.
All participants were 60 y or older with a Body Mass Index
(BMI) between 21–30 kg.m-2, were able to walk, sit down
and stand up independently and had the ability to sign in-
formed consent. Men and women were excluded from par-
ticipation if they had any (history of) gastrointestinal
disease, were diagnosed and actively treated for diabetes
mellitus type I or II, had a history of congestive heart failure
or recent hospitalization for heart disease or myocardial in-
farction, or had a history of hypoglycaemia. Other exclusion
criteria were: systolic blood pressure >180 mmHg and/or
diastolic blood pressure >110 mmHg, infection or fever in
the last 7 d, medication use (antibiotics within 3 wk prior
to study visit, current use of corticosteroids, growth hor-
mone or testosterone), known allergy to milk and milk
products, lactose intolerance and known galactosaemia, as
well as blood haemoglobin <9 g.dL-1. Moreover, those with
platelet count <100,000.mL-1, a history of hypo- or hyper-
coagulation disorders including use of a coumarin deriva-
tive, history of deep venous thrombosis, or pulmonary
embolism at any point in lifetime were also excluded. No
participants were involved in a weight loss or muscle
strengthening program, used protein containing or amino
acid containing nutritional supplements (within one week
of study entry), smoked (for the past 3 mo) or abused alco-
hol or drugs at time of screening and study visit. The Modi-
fied Baecke Questionnaire for Older Adults [21] was filled
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shows the flow diagram for participants.
All participants were informed of the procedures in-
volved and all possible risks before their informed consent
was obtained. The study was conducted according to
ICH-GCP principles, and in compliance with the princi-
ples of the ‘Declaration of Helsinki’ (59th WMA General
Assembly, Seoul, October 2008) and the local laws and
regulations of the country where the study was performed.
The study was approved by the Institutional Review Board
at the University of Arkansas for Medical Sciences.
Design
A randomised, controlled, double-blind, parallel groups,
single-centre study design was applied. After having
signed for informed consent at screening visit, participants
underwent a blood draw for Complete Blood Count ana-
lysis. Eligible participants underwent a DEXA-scan (dual
energy x-ray absorptiometry), and determination of 1-RM
(1-repetition maximum) for leg extension, and received
instructions and a diet diary for the 3-d standardization
phase preceding the study visit. At the study visit, partici-
pants were randomly allocated to receive one of the two
study products, using stratification for sex to account for
possible sexual dimorphism in muscle protein synthesis
response [22]. A 7¾-h isotope infusion protocol with sam-
pling of muscle biopsies and blood was followed toFigure 1 Flow diagram. Flow diagram of participants.determine postprandial mixed muscle protein synthesis
over 4 h after bolus intake of the study product. A unilat-
eral leg resistance exercise protocol, performed 15 min be-
fore ingestion of the nutritional product, enabled
measurement of muscle protein synthesis in both the rest-
ing and the exercising leg. Two follow-up phone calls, at
1–3 d and 5–10 d after the study visit, were scheduled for
identification of adverse events and evaluation of toler-
ance. Use of relevant concomitant medication and nutri-
tional supplements was recorded throughout the study.
Figure 2 shows a schematic representation of the study
design. Study staff and participants were blinded to the
study products until completion of the study database in-
cluding all laboratory data.
Standardization phase
Participants were advised to adhere to their regular dietary
intake, except from fasting state from 22:00 h the day
prior to the study visit. They were also asked not to take
part in any feast with excessive amounts of food for the
3 d prior to the study visit. Participants were requested
not to use alcohol within 24 h prior to the study visit, and
not to perform intense physical activities (i.e. sports, heavy
gardening and housekeeping, and walking or cycling lon-
ger than normal) for 72 h prior to the study visit. Dietary
intake was calculated based on the 3-d diet diary and
reviewed by a dietician. The mean daily dietary protein
screening visit 3-day standardization study visit follow-up calls
EXP group
Control group
N=23
N=10
N=10
1-leg exercise, T= -15min
product intake, T= 0
Prime-continuous IV [13C6]-phenylalanine isotope infusion
T=  -225min -45min 240min
muscle biopsy (Rest) 2 muscle biopsies (Rest/Exercise) 
blood samples (16x)
N=10 completers
N=10 completers
Figure 2 Study design. Study design, including a screening visit, a 3-d standardization period, study visit and follow-up calls. At the study visit,
participants underwent a stable isotope infusion protocol for 7¾ h, including an initial fasting period of 3¾ h until product intake (T = 0), regular
blood sampling (arrows), 3 muscle biopsies (T = −45 and 240 min), and an unilateral resistance exercise intervention (T = −15 min).
Table 1 Composition of the study products
Component Unit EXP
product
Control
product
Energy Kcal 150 150
Protein % 56 16
Carbohydrates % 26 66
Fat % 18 18
Protein Total g 21 61
Intact protein Whey g 20 1.2
Casein g 0 4.8
Free amino acid BCAA g 1 0
Total leucine2 g 3 0.6
Total EAA2 g 10.6 3.0
Total
phenylalanine
g 0.6 0.3
Carbohydrates Total g 10 25
Sucrose g 7.5 7.4
Glucose g 0 0.3
Maltose g 0 1.1
Maltodextrin g 2.2 15.9
Lactose g 0.05 0.07
Fat Total g 3 3
Palm oil g 2.9 2.9
Milk fat g 0 0.1
BCAA, branched chain amino acids; EAA, essential amino acids.
The study products contain no vitamins, trace elements, minerals, or
other additions.
1 Provided as milk protein.
2 Provided by protein and free BCAA.
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Food Processor, ESHA Research). Portion size reported by
the participants was evaluated based on pictures partici-
pants made of their meals.
Anthropometric measurements
Body height, body weight and body composition were
measured at the day of enrollment. Body weight and
height were used to calculate BMI. Body composition,
i.e. whole body fat mass, lean body mass and lean mass
of both legs (leg lean mass, LLM), was determined by
DEXA-scan using a Delphi DEXA scanner (QDR
4500W, Hologic Inc., Bedford, MA).
Study products
Both study products, i.e. Experimental and Control, pro-
vided 150 kcal (36 kJ) in a dose of 200 mL (Table 1).
The experimental study product (EXP) consisted of a
high whey protein, leucine-enriched nutritional supple-
ment (20 g whey protein, 3 g total leucine). The control
study product (Control) contained an amount of milk
protein (6 g protein) that is common for one serving of
a conventional dairy product, e.g. a glass of milk. The
amount and source of fat in the products were similar.
The amount of carbohydrates in the Control product
was higher and added as maltodextrin (19 DE). The
osmolality of the EXP product was slightly higher (400
mOsm.kg-1) compared with the Control product (350
mOsm.kg-1). The product had to be consumed com-
pletely as a single bolus, and all participants completed
consumption within 5 min. Study products were labelled
with randomization numbers, and independent site staff
mixed the study products (as powders) with water to a
volume of 200 mL prior to consumption.
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Participants reported to the lab in the morning of the
study visit after an overnight fast. An 18–22 gauge cath-
eter was placed into veins of the right and left forearms
for blood sampling and stable isotope infusion. All tim-
ings relate to the time of product intake as T0. Baseline
blood samples were collected for fasting concentrations
of serum C-reactive protein (CRP), albumin, and pre-
albumin, and background plasma amino acid enrichment
(T = −225 min). Thereafter, the plasma phenylalanine
pool was primed with a single intravenous priming
dose (4.2 μmol.kg-1) of L-[ring-13C6]-phenylalanine
(Cambridge Isotope Labs, Andover, MA). This was
followed immediately by a continuous infusion (0.07 μmol.
kg-1.min-1) of L-[ring-13C6]-phenylalanine and maintained
throughout the experiment. Blood was taken from the
sampling forearm at T = −105, -75, and −45 min, respec-
tively, for the determination of plasma phenylalanine en-
richment and concentrations of amino acids, glucose and
insulin. A first muscle biopsy was taken at T = −45 min
from the non-dominant leg. Unilateral resistance exercise
with the dominant leg was performed at T = −15 min with
the non-dominant leg in rest. Immediately following the
exercise protocol, a blood sample was taken followed by
bolus ingestion of the study product (200 mL at T0).
Blood samples were then drawn over the next 4 h, at 15,
30, 45, 60, 75, 90, 120, 150, 180, 210, 240 min after start
of product intake for analyses of amino acid enrich-
ments, and concentrations of amino acids, glucose and
insulin. Two more muscle biopsies, one from each
leg, were taken at 4 h after start of product intake at
T = 240 min.
The participants lay in bed throughout the study ex-
cept when they had to use the bathroom and during the
exercise protocol. Vital signs (blood pressure, heart rate,
body temperature and respiration rate) were recorded
once during the study visit, at baseline. Muscle biopsies
(50–100 mg) were taken under local anesthetic from the
lateral portion of the vastus lateralis, approximately 10–
15 cm above the knee, using a 5 mm Bergstrom biopsy
needle (Stille, Stockholm, Sweden). Muscle samples were
used to measure protein-bound phenylalanine enrich-
ment (as molar percent excess, MPE) for the purpose of
calculating mixed muscle protein fractional synthetic
rate (FSR). A tolerance questionnaire was taken before
product ingestion and at the end of the experiment to
record intensity of gastrointestinal symptoms (heartburn,
belching, nausea, vomiting, abdominal distension, fla-
tulence, diarrhea, and constipation), light-headedness,
headache, thirst, and dry mouth.
Unilateral leg resistance exercise protocol
Leg extensions were performed in seated position thru a
full range of motion using Keiser pneumatically controlledmachines with a starting angle of 110° of flexion. The
lower part of the dominant leg was conveniently placed
against the bar of the extender arm of the machine. Partic-
ipants performed a short warming-up of 5–10 unloaded
leg extensions, followed by 10 extensions at 40% of sub-
ject’s 1-RM, as determined during the screening visit. Dur-
ing a short break of maximum 2 min, the load was set at
80% of the subject’s 1-RM. Participants performed 4 sets
of 8–10 repetitions of leg extensions at 80% of 1-RM, with
counter-resisted flexion movement back to the starting
position. Duration ratio of extension and flexion move-
ment was 1:2. Resting interval between sets was 2 min.
The protocol lasted about 15 min. A trained instructor su-
pervised the exercise procedure.
Sample processing and analyses
Blood samples were collected in pre-chilled heparinized
tubes (Becton Dickinson Vacutainer system, Franklin
Lakes, New Jersey, USA) and kept on ice to minimize
enzymatic reactions. All plasma samples were stored
at −80°C until further analyses. Muscle samples were
prepared and processed as previously described [23].
Muscle free intracellular, protein-bound, and plasma
L-[ring-13C6]-phenylalanine enrichments were deter-
mined using the tert-butyldimethylsilyl derivative and
GCMS (Agilent Technologies model 5973) with electron
impact ionization as described previously [23]. Glucose
concentrations were measured using an YSI glucose
auto-analyzer. Amino acid concentrations in plasma
were measured by liquid chromatography-mass spec-
trometry using the internal standard approach for each
individual amino acid, as previously described [23].
Serum CRP and insulin concentrations were measured
by ELISA. Serum albumin and pre-albumin were ana-
lyzed using validated methods.
Calculations
The tracer-tracee ratio (t/T) was calculated from the dif-
ference in the area counts of the mass fragments from
234 and 240. Enrichment as MPE was then calculated as
(t/T)/(t/T + 1).
The primary endpoint of the study was the FSR (in %.h-1)
of mixed muscle protein. FSR is calculated by dividing the
increment in the enrichment in muscle protein-bound
13C6-phenylalanine over time (ΔMPEp) by the enrichment
of the precursor and the length of time between biopsies.
The mean plasma enrichment (MPE as area/time) of 13C6-
phenylalanine (Eplasma) between the two biopsies was
considered as the most representative precursor under this
non-steady state situation, anticipating that the different
phenylalanine content of the study products would
affect steady-state differently. Even more so because no
L-[ring-13C6]-phenylalanine was added to the study prod-
ucts to keep the blinded character of the study. This
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product intake, yielding comparable results to the trad-
itional intracellular precursor enrichment for calculation of
FSR, although absolute FSR levels are generally lower with
the plasma precursor [14,23]. FSR was thus calculated as
(ΔMPEp)/(Eplasma*t) * 60 *100, where t represents the
time interval between the two biopsies and the factors 60
and 100 are used to express FSR values in percent per hour.
FSR was calculated separately for the resting leg and the ex-
ercising leg, based on the increment in enrichment from
the first biopsy to the second biopsy in either of the 2 legs.
Since only one biopsy was taken in the postabsorptive
state, basal FSR could not be calculated according to the
traditional 2-biopsy method. In an attempt to calculate
basal FSR, the so-called single-biopsy calculation was ap-
plied [24] by using above equation of FSR where ΔMPEp
now represents the difference in 13C6-phenylalanine en-
richment between (a) muscle bound mixed protein from
the muscle biopsy taken at 180 min after the start of
tracer infusion and (b) plasma albumin protein from the
plasma sample taken before the start of tracer infusion
and reflecting background or natural protein enrich-
ment. However, since 6 out of 20 participants had partici-
pated in a previous tracer infusion study, and recent
publications indicate that nontracer naive state results in
unreliable muscle protein FSR [24], we decided to not in-
clude basal FSR values in the statistical analyses. There-
fore, the analysis on the primary parameter FSR was
performed on the postprandial data only, unadjusted for
basal FSR. Basal FSR values, calculated with data from
tracer naive participants, are only used as a reference to
estimate the increase in FSR after product intake.
For plasma leucine and EAA (sum of histidine, isoleu-
cine, leucine, lysine, methionine, phenylalanine, threo-
nine, tryptophan, and valine), the maximum (or peak)
plasma concentration, the maximum increment from
baseline and the iAUC (from baseline, during 4 h after
product intake) were calculated. For plasma AA (i.e.
sum of all amino acids), the iAUC was calculated. NEAA
was calculated as AA minus EAA. The postabsorptive
amino acid concentrations were only measured at −45
min, but will be indicated as T0. For plasma glucose and
insulin the maximum (or peak) and iAUC values were
calculated.
Statistical analysis
Mixed model analysis was used to compare postprandial
FSR values between the two groups; the model included
fixed effects for treatment, exercise and sex, a fixed
interaction effect for treatment * exercise and subject as
random factor. To compare postprandial values for other
parameters, the mixed model additionally included the
baseline pre-exercise values as a covariate. The check for
possible confounding factors was performed for theprimary parameter by including one-by-one (independ-
ently) BMI, body fat mass, LLM, age, physical activity,
mean daily dietary protein intake, or serum CRP concen-
tration in the basic model. For amino acids, glucose and
insulin, the serum CRP concentration was added to the
basic model as a potential confounder. A check for pos-
sible mediating factors was performed for the primary
parameter by including one-by-one (independently)
iAUC for AA, EAA, NEAA, leucine, glucose, and insulin,
as well as maximum concentrations for EAA and leucine
in the basic model and comparing the effect size of the
treatment effect in the model versus the effect size in
the model without possible mediator [25]. Pearson’s cor-
relation coefficients were calculated to analyse a correl-
ation between variables. Sample size calculation (10 per
group) was based on an anticipated difference in change
in FSR from baseline between EXP (50% estimated in-
crease) and Control group (11% estimated increase),
using a variance (SD2) of difference of 0.0003%/h (based
on [10,12]), an average within subject correlation over
time (ρ) of 0.7, an intra-class correlation coefficient
(ICC) for nested structure of 0.05, a significance level α
of 0.05, and a power of 80%.
SAS 9.1.3 (SAS Institute) software was used for all
statistical analyses. Data are expressed as means with
SEM, unless otherwise stated. Estimated marginal mean
(EMM) with SE, derived from the mixed model, is used
for overall analysis. Statistical significance was defined as
a two-tailed P < 0.05.
Results
Subjects
One subject was excluded from the data analysis because
of high plasma glucose concentration at baseline, which
increased further after product intake; all plasma glucose
values for that subject were above 8.3 mmol.L-1 (or
150 mg.dL-1). This was considered a major protocol de-
viation. Descriptive and statistical analyses are described
for the remaining 19 participants (per-protocol analyses).
No significant differences were present in demographics,
body composition, screening parameters, and pre-study
dietary protein intake between the two groups (Table 2).
The participants in the two groups did not differ in their
medical history, and no clinically relevant differences in
adverse events and gastrointestinal symptoms were ob-
served between both groups.
Plasma amino acids, glucose and insulin
Plasma concentrations of leucine, EAA, and AA over
time are shown in Figure 3. Baseline values were not dif-
ferent between groups (P > 0.70). EXP product intake re-
sulted in a significantly higher peak plasma leucine
concentration (406 ± 35 μmol.L-1) than intake of the
Control product (142 ± 5 μmol.L-1; P < 0.001). Change in
Table 2 Demographic data and other subject characteristics at baseline (per-protocol population)1
Characteristic EXP (n = 9) Control (n = 10) Total (n = 19) P value2
Male/female, n 4/5 5/5 9/10 1.00
Age, y 66.9 ± 4.8 71.1 ± 6.3 69.1 ± 5.9 0.12
Body weight, kg 79.90 ± 12.23 78.75 ± 13.89 79.29 ± 12.78 0.85
BMI, kg.m-2 27.08 ± 1.88 26.14 ± 2.59 26.58 ± 2.27 0.38
Fat mass, kg 25.88 ± 4.62 25.72 ± 8.21 25.80 ± 6.57 0.96
Lean body mass, kg 49.17 ± 10.07 48.11 ± 10.04 48.61 ± 9.79 0.82
Leg lean mass3, kg 15.83 ± 3.75 15.30 ± 3.91 15.55 ± 3.74 0.77
Serum albumin, g.L-1 2.782 ± 0.335 3.033 ± 0.464 2.914 ± 0.417 0.20
Serum pre-albumin, g.L-1 0.285 ± 0.132 0.252 ± 0.152 0.268 ± 0.140 0.63
Serum CRP, mg.L-1 1.932 ± 1.532 1.620 ± 1.534 1.768 ± 1.498 0.66
Physical activity level, total score 7.526 ± 2.766 11.363 ± 5.688 9.545 ± 4.843 0.08
1-RM for single leg extension, Nm 96.3 ± 38.7 76.3 ± 25.7 85.8 ± 33.2 0.20
Dietary protein intake, g.kg BW-1.day-1 0.8689 ± 0.1913 1.0136 ± 0.2358 0.9451 ± 0.2226 0.16
Dietary protein intake, % 15.96 ± 2.48 17.97 ± 2.99 17.02 ± 2.88 0.14
1 All values are means ± SD, except for sex.
2 P value is based on two-sample t-test, except for sex a Fisher exact test is used.
3 Sum of both legs.
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μmol.L-1) vs Control (58 ± 6 μmol.L-1) (P < 0.001), as was
iAUC leucine (40471 ± 2655 and 6344 ± 971 μmol.L-1.
min for EXP and Control respectively; P < 0.001). Peak
plasma EAA concentration was significantly higher in
EXP (2227 ± 139 μmol.L-1) vs Control (1180 ± 33 μmol.
L-1)(P < 0.001), as was change in EAA (1306 ± 148 and
249 ± 32 μmol.L-1 for EXP and Control respectively;
P < 0.001), and iAUC EAA (142281 ± 11931 and 17312 ±
2638 μmol.L-1.min-1 for EXP and Control respectively;
P < 0.001). For AA, iAUC was significantly higher after
ingestion of EXP (206229 ± 23889 μmol.L-1.min-1) than
Control (39244 ± 11490 μmol.L-1.min-1)(P < 0.001).
Plasma concentrations of insulin and glucose over
time are shown in Figure 4. Baseline glucose was not dif-
ferent between EXP and Control, both before and after
exercise (both P > 0.60). Ingestion of the Control product
increased plasma glucose concentration to a significantly
higher peak concentration (8.5 ± 0.4 mmol.L-1) than did
the EXP product (6.4 ± 0.3 mmol.L-1)(P < 0.001). iAUC
glucose was also higher for Control (246 ± 37 mmol.L-1.
min-1) vs EXP (88 ± 15 mmol.L-1.min-1) (P = 0.003). No
significant differences between EXP and Control were
observed for baseline insulin either before exercise
(P = 0.30) or after exercise (P = 0.19), and for peak
plasma insulin (P = 0.17) and iAUC insulin (P = 0.17).L-[ring]-13C6-phenylalanine enrichments
Plasma enrichment of L-[ring-13C6]-phenylalanine
showed a stable level (steady state) before ingestion of
the study products (Figure 5). The profiles suggestedthat product ingestion caused a disruption in steady
state of plasma L-[ring-13C6]-phenylalanine enrichment.
Mixed muscle protein-bound enrichment (MPE) of L-
[ring-13C6]-phenylalanine was 0.031 ± 0.005% (T-45 min),
0.063 ± 0.004% (T240 resting leg) and 0.073 ± 0.012%
(T240 min exercising leg) in the EXP group. In the Con-
trol group, MPE was 0.038 ± 0.013% (T-45 min), 0.065 ±
0.013% (T240 resting leg) and 0.069 ± 0.013% (T240 min
exercising leg). Muscle free intracellular enrichment
(MPE) of L-[ring-13C6]-phenylalanine was 7.483 ± 0.514%
(T-45 min), 9.275 ± 0.642% (T240 resting leg) and 8.636 ±
0.990% (T240 min exercising leg) in the EXP group. In the
Control group, MPE was 8.119 ± 0.683% (T-45 min),
8.995 ± 0.411% (T240 resting leg) and 9.579 ± 0.505%
(T240 min exercising leg).Mixed muscle protein synthesis rate (FSR)
The calculated one-biopsy baseline muscle protein syn-
thesis rate (FSR) was 0.053 ± 0.010 %.h-1 and 0.052 ±
0.017 %.h-1 for EXP and Control group, respectively.
Postprandial FSR overall was significantly higher after
ingestion of the EXP product (0.078 ± 0.007 %.h-1
(EMM± SE)) than after ingestion of the Control product
(0.057 ± 0.007 %.h-1 (EMM± SE)) (P = 0.049) (Figure 6).
No interaction between treatment and exercise was ob-
served (P = 0.52), indicating a similar effect of the EXP
vs Control product during rest (P = 0.11) and exercise
(P = 0.14). When comparing the resting and exercising
leg, no significant differences are observed between the
legs in the Control group (P = 0.0564) and EXP group
(P = 0.2908). The estimated mean FSR increase from the
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Figure 3 (See legend on next page.)
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Figure 3 Plasma amino acids. Plasma concentrations (means ± SEM) of leucine, essentials amino acids (EAA), sum of amino acids (AA),
isoleucine, valine and phenylalanine before and after ingestion (at T = 0) of the study products EXP (n = 9) and Control (n = 10). Baseline values
were not different between groups. iAUC values for leucine, EAA and AA were significantly higher after ingestion of EXP vs Control (P < 0.001).
For leucine and EAA, peak and change-from-baseline concentrations were also significantly higher after ingestion of EXP vs Control (P < 0.001).
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Figure 4 Plasma glucose and insulin. Plasma concentrations (means ± SEM) of glucose and insulin before and after ingestion (at T = 0) of the
study products EXP (n = 9) and Control (n = 10). Baseline values were not different between groups. Peak glucose (P < 0.001) and glucose iAUC
(P = 0.003) was significantly higher after ingestion of Control, but groups did not differ significantly in peak or iAUC insulin.
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Figure 5 Plasma 13C6-Phe enrichment. Plasma enrichment of L-[ring-
13C6]-phenylalanine (means ± SEM) expressed as molar percent excess
(MPE), before and after ingestion (at T = 0) of the study products EXP (n = 9) and Control (n = 10).
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http://www.nutritionj.com/content/13/1/9calculated baseline in the resting leg was 28% for EXP
and 3% for Control. Postprandial FSR values calculated
using the muscle free amino acid as precursor indicate a
similar pattern as observed with the plasma precursor
pool: 0.087 ± 0.006%/h (resting leg) and 0.138 ± 0.045%/h
(exercising leg) in the EXP group, and 0.0754 ± 0.025%/h
(resting leg) and 0.083 ± 0.008%/h (exercising leg) in the
Control group.
When including possible confounding parameters
one-by-one in the statistical model, the P value for dif-
ference in postprandial FSR overall increased from 0.049
(basic model) to 0.15 when including physical activity,
and to 0.15 when including dietary protein intake (as en0
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p=0.049
Figure 6 Mixed muscle protein synthesis. Mixed muscle protein FSR (m
4 h after ingestion of the study products EXP (n = 9) and Control (n = 10). D%). Inclusion of LLM in the basic model lowered the
P value from 0.049 to 0.024, but no significant correl-
ation was observed between postprandial FSR overall
and LLM (P = 0.82).
When expressing the intake of total protein from EXP
(21g) and Control (6g) per kg LLM, a significant correl-
ation was observed with the resting postprandial FSR
(r = 0.48, P = 0.038) but not with the exercising postpran-
dial FSR (P = 0.29)(Figure 7).
Possible mediating factors to the FSR effect
Several parameters were included one-by-one in the basic
mixed model to identify the factors related to productEXP
Resting leg
Exercising leg
eans ± SEM) with plasma L-[ring-13C6]-phenylalanine as precursor, over
ata are presented for resting leg and exercising leg separately.
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Figure 7 Correlation between FSR and leg lean mass-corrected
protein intake. Correlation between intake of protein from EXP
(21 g) and Control (6 g) per kg leg lean mass (LLM) and postprandial
FSR in the resting leg. Pearson’s correlation statistics is shown.
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fect. iAUC leucine and iAUC EAA appeared the strongest
mediators, changing the P value in the model from 0.049
to 0.99 and 0.85, respectively. Including iAUC AA, max-
imum leucine and maximum EAA in the statistical model,
moderately changed the P value to 0.55, 0.52 and 0.49, re-
spectively. NEAA and glucose only slightly mediated the
FSR response (P value changed to 0.18 and 0.14, respect-
ively), while insulin did not mediate the FSR response (no
change in P value).
This is also shown by the correlations between
postprandial FSR overall and iAUC leucine (r = 0.35,
P = 0.031), iAUC EAA (r = 0.34, P = 0.034), maximum
leucine (r = 0.32, P = 0.05), and maximum EAA (r = 0.31,
P = 0.06). iAUC NEAA was not significantly correlated
with postprandial FSR overall (P = 0.18).
Discussion
A significantly higher overall postprandial muscle pro-
tein synthesis rate was observed after intake of the spe-
cifically designed high whey protein, leucine-enriched
nutritional supplement, as compared with the isocaloric
control product containing milk protein in an amount
that is typical for a single serving of a conventional dairy
product. In this study using the unilateral resistance ex-
ercise model, we did not observe a further enhanced
postprandial muscle protein synthesis response.
Postprandial FSR response and product-related factors
In line with our hypothesis, a nutritional supplement con-
taining 20 g whey protein with added free leucine to a
total amount of 3 g leucine resulted in a greater overall
mixed muscle protein synthesis rate during the 4-h post-
prandial period (0.0780 ± 0.0070%/h) than 6g milk protein
in an iso-caloric product (0.0574 ± 0.0066%/h). Previous
studies showed greater stimulation of postprandial
muscle protein synthesis with a higher amount of total
leucine (~2.8-3.5 g leucine in a mixture of 6.7 g EAA oradded to 20g casein protein) [12,26], a higher dose of
EAA (~10-15 g) [7,11,27], or a higher amount of whey
protein (~20-35 g) [14,15,28], when compared to a low
amount of EAA (7 g), a lower amount of whey protein
(10-20 g) or 20 g casein protein alone. Our data extend
on this previous work by showing that a combination,
i.e. 20 g whey protein, 11 g total EAA and 3 g total leu-
cine, is effective for stimulation of overall muscle pro-
tein synthesis in the context of a nutritional supplement
that contained also fat and carbohydrates besides pro-
tein. In line with previous findings we also observed that
an increase in plasma EAA and leucine likely dictates
the extent of stimulation of muscle protein synthesis
[9,10,12,14,29] while plasma NEAA attribute much less
to postprandial muscle protein synthesis [9,10]. The lar-
ger amount of carbohydrates in the iso-caloric Control
product resulted in a rapid increase of plasma glucose
to a higher peak concentration and iAUC compared
with the EXP product that contained fewer carbohy-
drates. However, the insulin response to both products
was similar, which is likely due to leucine-stimulated insu-
lin secretion in the EXP product [30,31], and stimulation
of insulin release by the high carbohydrate content in the
Control product. Adding insulin as a possible mediator in
the statistical model indicated that the FSR response was
not related to alterations in serum insulin in our study,
which confirms that the observed difference in muscle
protein synthesis response between the products is at least
not due to a difference in endogenous insulin release. The
role of insulin on muscle protein synthesis is somewhat
debated and inhibition of muscle protein breakdown by
insulin may be even more important [32]. In existing stud-
ies in healthy older participants, the addition of carbohy-
drates has not been shown to augment muscle protein
FSR [33], and one study demonstrated a blunted FSR re-
sponse with carbohydrates added to a mixture of amino
acids [4]. It can also be hypothesized that a decrease of
protein breakdown lowered amino acid availability if no
nutrients were given and FSR would then have likely de-
creased, even though net balance might have improved.
An important limitation of the present study design there-
fore is the absence of protein breakdown measures. In
particular in the context of a mixed meal, the total ana-
bolic response to protein is ultimately a function of
muscle protein synthesis and protein breakdown as also
reflected by a linear relation between protein intake and
net protein synthesis [27].
Postprandial FSR response at rest
The postprandial FSR response was significantly higher
after intake of the high whey protein, leucine-enriched
product in the overall comparison, but the difference
was not significant for the resting condition as such.
Lack of statistical power and inter-individual variation in
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sample size to 25 participants per group would have
increased the power from 40% to 80% to show a post-
prandial FSR difference between the two groups in rest.
A cross-over design or comparison between the groups
of the FSR increase (i.e. change from baseline) could
have reduced the variation, favoring statistical significant
difference between the two groups.
The estimated 3% increase of postprandial FSR with the
Control product suggests that a conventional dairy pro-
duct is not adequate to acutely stimulate muscle protein
synthesis in older people, as expected from the protein/
EAA content of the dairy product that is below 7 g EAA
[11]. The 28% estimated increase of postprandial mixed
muscle FSR with the high whey protein, leucine-enriched
nutritional supplement seems somewhat less than pre-
viously observed values with 2.8 g leucine in a mix of 6.7 g
EAA [12], 15 g EAA [7,10], or compared with the dif-
ference in postprandial FSR between 20 g whey and 20 g
casein protein [14]. However, the effect is in line with the
16% increase from basal with 20 g whey protein in a re-
cent study in older adults [34]. While our study products
contained also carbohydrates and fat to mimic conven-
tional nutrition, all previous studies referred to above used
supplementation of protein only without the addition of
carbohydrates or fat. The combined effect of additional
macronutrients on postprandial FSR response to protein
intake therefore needs further investigation to define the
effect of added carbohydrates and fat.
Postprandial FSR response with combined exercise
Combined exercise showed a similar effect in both groups
(no interaction) in our study, but the variation in FSR re-
sponse to the combined exercise-nutrition intervention
was large. It has previously been observed that the muscle
protein synthesis response to exercise alone is impaired in
older people [5,6]. But when combined with ingestion of
20 g casein [35] or 90 g beef protein [36], resistance exer-
cise increased mixed muscle protein FSR to a higher level
than dietary intervention alone, similar to the young. A re-
cent dose–response study with whey protein (0, 10, 20
and 40 g) in older men showed that at least 20 g of whey
was required to increase myofibrillar FSR above exercise
alone [28]. Moreover, resistance exercise-stimulated myo-
fibrillar FSR was greater after ingestion of 20 g whey pro-
tein than after 20 g casein protein [15]. It is possible that a
higher protein amount in the supplement or measuring
the synthesis of myofibrillar proteins, which are affected
to a greater degree by resistance exercise than other
muscle proteins [37], would have resulted in a significant
effect of combined exercise. Another aspect demonstrated
by Drummond et al. [20] is that, in contrast to young, re-
sistance exercise before ingestion of 20 g EAA only stimu-
lated muscle protein synthesis at 3–6 h post-exercise andnot during the first 3 h post-exercise in older people. It is
therefore possible that the 4-h interval for studying muscle
protein synthesis in our study was too short to show an ef-
fect of combined exercise.
Subject characteristics that potentially influence the FSR
response
Interestingly, the inclusion of LLM in the mixed model in-
creased the statistical power in our study. When the protein
intake from the supplements was then expressed per kg
LLM, a significant correlation was observed with resting
postprandial FSR. It is therefore likely that the degree of
muscle anabolic response to product supplementation is
also dependent of the LLM of the subject. The data seem
indicative of a dose–response relation between protein and
FSR when LLM is taken into account. However, various
dosages of the same protein source and different protein
sources should be tested to discriminate between protein
amount and source in such relationship. Moreover, we ob-
served that both habitual protein intake (as en%) and phys-
ical activity level reduced the statistical power when
included in the mixed model. Although both variables were
not strong confounders (i.e. P value below 0.2 after inclu-
sion in the mixed model), it may point toward potential
relevance of these factors in the muscle anabolic response.
Physical activity level and composition of the habitual diet
have both been suggested to be related to a blunted muscle
protein synthesis response to nutritional stimuli [38].
Therefore, the relevance of LLM, habitual dietary protein
intake (as en%) and physical activity level for the acute
muscle anabolic response in older people needs further
study. Especially in sarcopenic older adults, since this group
is generally characterized by lower LLM, lower dietary pro-
tein intake and a lower physical activity level.
Conclusions
A specifically designed nutritional supplement high in
whey protein and enriched in leucine is more effective
than a conventional dairy product to stimulate postpran-
dial muscle protein synthesis overall in healthy older
subjects. This effect is attributable to the higher plasma
levels of leucine and EAA after intake of the high whey
protein, leucine-enriched supplement, while changes in
plasma NEAA are of less relevance and plasma insulin
increase does not dictate the FSR response. Moreover,
the effects on protein breakdown and the impact of
other macronutrients on the anabolic effect of protein
needs further study, as well as the effect of subject char-
acteristics leg lean mass, habitual protein intake and
physical activity level. Finally, this acute effect on post-
prandial muscle protein synthesis is promising for po-
tential long-term effects on parameters of muscle mass,
strength and function in sarcopenic older people. This
requires further study.
Luiking et al. Nutrition Journal 2014, 13:9 Page 13 of 14
http://www.nutritionj.com/content/13/1/9Competing interests
This study was financially supported and study products were provided by
Nutricia Advanced Medical Nutrition, Danone Research, the Netherlands.
All authors have made substantial contributions to the conception and
design of the study, acquisition of data, analysis and interpretation of data,
drafting and critically revising the article for intellectual content. Each author
has seen and approved the contents of the submitted manuscript.
YCL, RM and SV are employed by Nutricia Advanced Medical Nutrition. YCL
has also an affiliation at CTRAL. RRW was a member of the Danone Research
Advisory Board at the time of study and received compensation. NEPD has
no conflict of interest to declare.
Authors’ contributions
YCL was involved in writing of the protocol, the statistical analysis plan, data
interpretation and drafting the manuscript. NEPD was involved in data
interpretation. RM was involved in study coordination, writing the protocol
and the statistical analysis plan. SV initiated the study and was involved in
data interpretation. RRW was principle investigator of the study, and
involved in all aspects of the study. All authors approved the final draft of
the manuscript.
Acknowledgements
We thank the staff involved in the study at CTRAL UAMS for their assistance:
S. Schutzler (study coordinator and research nurse), A.A. Ferrando (sub-
investigator), S. Ward (study recruiter and exercise instructor), P. Kortebein
(study physician), C. Moffitt, L. Xu and J.J. Thaden (samples analysis), J.D.
Davis (research nurse), O. Kajkenova and D. Bodenner (biopsy sampling).
Moreover, we thank the staff involved in the study at Nutricia Advanced
Medical Nutrition: G. Hofman (data monitoring and study coordination), E.
Verdonk (data management), S. Swinkels (statistical review), B. Draaijer and F.
de Vries (statistical analyses), and C. Verduyn (safety monitoring).
Author details
1Nutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, the
Netherlands. 2Center for Translational Research in Aging and Longevity,
Department of Health & Kinesiology, Texas A&M University, College Station,
TX, USA. 3Center for Translational Research in Aging and Longevity, Donald
W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences,
4301 W. Markham St. Slot 806, Little Rock AR 72205, USA.
Received: 25 September 2013 Accepted: 20 January 2014
Published: 22 January 2014
References
1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC,
Michel JP, Rolland Y, Schneider SM, et al: Sarcopenia: European consensus on
definition and diagnosis: report of the European working group on
sarcopenia in older people. Age Ageing 2010, 39:412–423.
2. Guillet C, Prod’homme M, Balage M, Gachon P, Giraudet C, Morin L, Grizard J,
Boirie Y: Impaired anabolic response of muscle protein synthesis is
associated with S6K1 dysregulation in elderly humans. Faseb J 2004,
18:1586–1587.
3. Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P,
Wackerhage H, Taylor PM, Rennie MJ: Anabolic signaling deficits underlie
amino acid resistance of wasting, aging muscle. Faseb J 2005, 19:422–424.
4. Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR: The response of muscle
protein anabolism to combined hyperaminoacidemia and glucose-
induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol
Metab 2000, 85:4481–4490.
5. Fry CS, Drummond MJ, Glynn EL, Dickinson JM, Gundermann DM,
Timmerman KL, Walker DK, Dhanani S, Volpi E, Rasmussen BB: Aging
impairs contraction-induced human skeletal muscle mTORC1 signaling
and protein synthesis. Skelet Muscle 2011, 1:11.
6. Kumar V, Selby A, Rankin D, Patel R, Atherton P, Hildebrandt W, Williams J,
Smith K, Seynnes O, Hiscock N, Rennie MJ: Age-related differences in the
dose–response relationship of muscle protein synthesis to resistance
exercise in young and old men. J Physiol 2009, 587:211–217.
7. Paddon-Jones D, Sheffield-Moore M, Zhang XJ, Volpi E, Wolf SE, Aarsland A,
Ferrando AA, Wolfe RR: Amino acid ingestion improves muscle protein
synthesis in the young and elderly. Am J Physiol Endocrinol Metab 2004,
286:E321–E328.8. Volpi E, Ferrando AA, Yeckel CW, Tipton KD, Wolfe RR: Exogenous amino
acids stimulate net muscle protein synthesis in the elderly. J Clin Invest
1998, 101:2000–2007.
9. Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR: Essential
amino acids are primarily responsible for the amino acid stimulation of
muscle protein anabolism in healthy elderly adults. Am J Clin Nutr 2003,
78:250–258.
10. Paddon-Jones D, Sheffield-Moore M, Katsanos CS, Zhang XJ, Wolfe RR:
Differential stimulation of muscle protein synthesis in elderly humans
following isocaloric ingestion of amino acids or whey protein. Exp
Gerontol 2006, 41:215–219.
11. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR: Aging
is associated with diminished accretion of muscle proteins after the
ingestion of a small bolus of essential amino acids. Am J Clin Nutr 2005,
82:1065–1073.
12. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR: A high
proportion of leucine is required for optimal stimulation of the rate of
muscle protein synthesis by essential amino acids in the elderly. Am J
Physiol Endocrinol Metab 2006, 291:E381–E387.
13. Casperson SL, Sheffield-Moore M, Hewlings SJ, Paddon-Jones D: Leucine
supplementation chronically improves muscle protein synthesis in older
adults consuming the RDA for protein. Clinical nutrition 2012, 31:512–519.
14. Pennings B, Boirie Y, Senden JM, Gijsen AP, Kuipers H, Van Loon LJ: Whey
protein stimulates postprandial muscle protein accretion more
effectively than do casein and casein hydrolysate in older men. Am J Clin
Nutr 2011, 93:997–1005.
15. Burd NA, Yang Y, Moore DR, Tang JE, Tarnopolsky MA, Phillips SM: Greater
stimulation of myofibrillar protein synthesis with ingestion of whey
protein isolate v. micellar casein at rest and after resistance exercise in
elderly men. Br J Nutr 2012, 108:1–5.
16. Biolo G, Maggi SP, Williams BD, Tipton KD, Wolfe RR: Increased rates of
muscle protein turnover and amino acid transport after resistance
exercise in humans. Am J Physiol 1995, 268:E514–E520.
17. Tang JE, Manolakos JJ, Kujbida GW, Lysecki PJ, Moore DR, Phillips SM:
Minimal whey protein with carbohydrate stimulates muscle protein
synthesis following resistance exercise in trained young men. Appl
Physiol Nutr Metab 2007, 32:1132–1138.
18. Biolo G, Tipton KD, Klein S, Wolfe RR: An abundant supply of amino acids
enhances the metabolic effect of exercise on muscle protein.
Am J Physiol 1997, 273:E122–E129.
19. Dreyer HC, Drummond MJ, Pennings B, Fujita S, Glynn EL, Chinkes DL,
Dhanani S, Volpi E, Rasmussen BB: Leucine-enriched essential amino acid
and carbohydrate ingestion following resistance exercise enhances
mTOR signaling and protein synthesis in human muscle. Am J Physiol
Endocrinol Metab 2008, 294:E392–E400.
20. Drummond MJ, Dreyer HC, Pennings B, Fry CS, Dhanani S, Dillon EL,
Sheffield-Moore M, Volpi E, Rasmussen BB: Skeletal muscle protein
anabolic response to resistance exercise and essential amino acids is
delayed with aging. J Appl Physiol 2008, 104:1452–1461.
21. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA: A
physical activity questionnaire for the elderly. Med Sci Sports Exerc 1991,
23:974–979.
22. Smith GI, Atherton P, Villareal DT, Frimel TN, Rankin D, Rennie MJ,
Mittendorfer B: Differences in muscle protein synthesis and anabolic
signaling in the postabsorptive state and in response to food in 65–80
year old men and women. PLoS One 2008, 3:e1875.
23. Deutz NE, Safar A, Schutzler S, Memelink R, Ferrando A, Spencer H, Van
Helvoort A, Wolfe RR: Muscle protein synthesis in cancer patients can be
stimulated with a specially formulated medical food. Clinical nutrition
2011, 30:759–768.
24. Burd NA, Pennings B, Groen BB, Gijsen AP, Senden JM, Van Loon LJ: The single
biopsy approach is reliable for the measurement of muscle protein
synthesis rates in vivo in older men. J Appl Physiol 2012, 113:896–902.
25. Baron RM, Kenny DA: The moderator-mediator variable distinction in
social psychological research: conceptual, strategic, and statistical
considerations. J Pers Soc Psychol 1986, 51:1173–1182.
26. Wall BT, Hamer HM, De Lange A, Kiskini A, Groen BB, Senden JM, Gijsen AP,
Verdijk LB, Van Loon LJ: Leucine co-ingestion improves post-prandial muscle
protein accretion in elderly men. Clinical nutrition 2013, 32:412–419.
27. Deutz NE, Wolfe RR: Is there a maximal anabolic response to protein
intake with a meal? Clin Nutr 2013, 32:309–313.
Luiking et al. Nutrition Journal 2014, 13:9 Page 14 of 14
http://www.nutritionj.com/content/13/1/928. Yang Y, Breen L, Burd NA, Hector AJ, Churchward-Venne TA, Josse AR,
Tarnopolsky MA, Phillips SM: Resistance exercise enhances myofibrillar
protein synthesis with graded intakes of whey protein in older men.
Br J Nutr 2012, 28:1–9.
29. Rieu I, Balage M, Sornet C, Giraudet C, Pujos E, Grizard J, Mosoni L, Dardevet
D: Leucine supplementation improves muscle protein synthesis in
elderly men independently of hyperaminoacidaemia. J Physiol 2006,
575:305–315.
30. Newsholme P, Brennan L, Rubi B, Maechler P: New insights into amino
acid metabolism, beta-cell function and diabetes. Clin Sci (Lond) 2005,
108:185–194.
31. Koopman R, Verdijk LB, Beelen M, Gorselink M, Kruseman AN, Wagenmakers
AJ, Kuipers H, Van Loon LJ: Co-ingestion of leucine with protein does not
further augment post-exercise muscle protein synthesis rates in elderly
men. Br J Nutr 2008, 99:571–580.
32. Greenhaff PL, Karagounis LG, Peirce N, Simpson EJ, Hazell M, Layfield R,
Wackerhage H, Smith K, Atherton P, Selby A, Rennie MJ: Disassociation
between the effects of amino acids and insulin on signaling, ubiquitin
ligases, and protein turnover in human muscle. Am J Physiol Endocrinol
Metab 2008, 295:E595–E604.
33. Hamer HM, Wall BT, Kiskini A, De Lange A, Groen BB, Bakker JA, Gijsen AP,
Verdijk LB, Van Loon LJ: Carbohydrate co-ingestion with protein does not
further augment post-prandial muscle protein accretion in older men.
Nutr Metab (Lond) 2013, 10:15.
34. Pennings B, Groen B, De Lange A, Gijsen AP, Zorenc AH, Senden JM, Van
Loon LJ: Amino acid absorption and subsequent muscle protein
accretion following graded intakes of whey protein in elderly men.
Am J Physiol Endocrinol Metab 2012, 302:E992–E999.
35. Pennings B, Koopman R, Beelen M, Senden JM, Saris WH, Van Loon LJ:
Exercising before protein intake allows for greater use of dietary
protein-derived amino acids for de novo muscle protein synthesis in
both young and elderly men. Am J Clin Nutr 2010, 93:322–331.
36. Symons TB, Sheffield-Moore M, Mamerow MM, Wolfe RR, Paddon-Jones D:
The anabolic response to resistance exercise and a protein-rich meal is
not diminished by age. J Nutr Health Aging 2011, 15:376–381.
37. Moore DR, Tang JE, Burd NA, Rerecich T, Tarnopolsky MA, Phillips SM:
Differential stimulation of myofibrillar and sarcoplasmic protein
synthesis with protein ingestion at rest and after resistance exercise.
J Physiol 2009, 587:897–904.
38. Burd NA, Wall BT, Van Loon LJ: The curious case of anabolic resistance:
old wives’ tales or new fables? J Appl Physiol 2012, 112:1233–1235.
doi:10.1186/1475-2891-13-9
Cite this article as: Luiking et al.: Postprandial muscle protein synthesis
is higher after a high whey protein, leucine-enriched supplement than
after a dairy-like product in healthy older people: a randomized
controlled trial. Nutrition Journal 2014 13:9.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
